Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Embrella Cardiovascular brings in $5.1mm through its Series B, adds on

Executive Summary

Embrella Cardiovascular (developing a device that provides cerebral embolic protection during cardiovascular surgeries) has raised $5.1mm through its Series B round. First-time backer Bio-Star Ventures co-led the financing with current shareholder Medfocus Fund and were joined by new investor Edwards Lifesciences as well as 28 other new and returning private investors.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies